Qiagen (QGEN) Q3 Earnings and Revenues Top Estimates

Core Viewpoint - Qiagen reported quarterly earnings of $0.57 per share, exceeding the Zacks Consensus Estimate of $0.54 per share, and showing an increase from $0.52 per share a year ago, representing an earnings surprise of 5.56% [1] Financial Performance - The company posted revenues of $501.87 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 2.31%, and up from $475.89 million year-over-year [2] - Over the last four quarters, Qiagen has exceeded consensus EPS estimates three times and topped consensus revenue estimates four times [2] Stock Performance and Outlook - Qiagen shares have declined approximately 1.8% since the beginning of the year, contrasting with the S&P 500's gain of 21.2% [3] - The current consensus EPS estimate for the upcoming quarter is $0.59 on revenues of $522.77 million, and for the current fiscal year, it is $2.15 on revenues of $1.97 billion [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Qiagen belongs, is currently ranked in the top 38% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]